Every open market buy and sale of Enanta Pharmaceuticals Inc stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $183K sold.
Buying and selling by month
open market, last 12 monthsGet an alert when ENTA insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an ENTA officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every ENTA insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | Jay R. LulyPresident and CEO | Sale | 4,743 | $14.23 | $67K | 858,026 | Dec 5Form 4 |
| Dec 5, 2025 | Yat Sun OrChief Scientific Officer | Sale | 2,390 | $14.23 | $34K | 371,392 | Dec 5Form 4 |
| Dec 5, 2025 | Tara Lynn KiefferChief Product Strategy Officer | Sale | 2,106 | $14.23 | $30K | 30,620 | Dec 5Form 4 |
| Dec 5, 2025 | Brendan LuuChief Business Officer | Sale | 1,394 | $14.23 | $20K | 38,329 | Dec 5Form 4 |
| Dec 5, 2025 | Scott T. RottinghausChief Medical Officer | Sale | 798 | $14.23 | $11K | 21,792 | Dec 5Form 4 |
| Dec 5, 2025 | Harry R. Trout IIISee Remarks | Sale | 542 | $14.23 | $8K | 16,348 | Dec 5Form 4 |
| Dec 5, 2025 | Kathleen S. CappsSee Remarks | Sale | 323 | $14.23 | $5K | 8,377 | Dec 5Form 4 |
| Dec 2, 2025 | Harry R. Trout IIISee Remarks | Sale | 380 | $13.96 | $5K | 16,890 | Dec 3Form 4 |
| Dec 2, 2025 | Kathleen S. CappsSee Remarks | Sale | 207 | $13.96 | $3K | 8,700 | Dec 3Form 4 |
| Feb 12, 2025 | Jay R. LulyPresident and CEO | Buy | 45,000 | $5.69 | $256K | 846,638 | Feb 12Form 4 |
| Dec 6, 2024 | Jay R. LulyPresident and CEO | Sale plan | 5,142 | $8.06 | $41K | 801,638 | Dec 10Form 4 |
| Dec 6, 2024 | Paul J MellettChief Fin. & Admin Officer | Sale plan | 2,591 | $8.06 | $21K | 91,710 | Dec 10Form 4 |
| Dec 6, 2024 | Yat Sun OrChief Scientific Officer | Sale plan | 2,591 | $8.06 | $21K | 369,109 | Dec 10Form 4 |
| Dec 6, 2024 | Scott T. RottinghausChief Medical Officer | Sale plan | 866 | $8.06 | $7K | 17,918 | Dec 10Form 4 |
| Dec 6, 2024 | Brendan LuuChief Business Officer | Sale plan | 2,283 | $8.06 | $18K | 36,047 | Dec 10Form 4 |
ENTA insider trading FAQ
Are ENTA insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of ENTA on the open market in 0 trades, and 7 sold $183K in 9 trades.
When did an ENTA insider last buy shares?
Jay R. Luly (President and CEO) bought 45,000 shares for $256K on Feb 12, 2025, reported on Feb 12, 2025.
When did an ENTA insider last sell shares?
Jay R. Luly (President and CEO) sold 4,743 shares for $67K on Dec 5, 2025.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
